Document Type : Review Article
Authors
1 Faculty of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran
2 Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
3 Department of Management, Policy Making and Health Economics, Faculty of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran
4 Department of Public Health, Khoy University of Medical Sciences, Khoy, Iran
Abstract
Introduction: This study aimed to critically examine the vulnerabilities of healthcare systems to corruption and to analyze corrupt practices in the procurement of pharmaceuticals and medical supplies during crises, with a particular focus on the COVID-19 pandemic.
Methods: This comprehensive scoping review was conducted in 2024 following the methodological framework proposed by Arksey and O’Malley. The literature search encompassed four major electronic databases, supplemented by manual searches of relevant reports, conference proceedings, and gray literature. A two-reviewer screening process was implemented to determine eligibility based on predefined inclusion and exclusion criteria. Data extraction was performed using a standardized form, and results were synthesized in tabular format to facilitate the identification of key concepts, types of evidence, and research gaps concerning corruption in the procurement of essential medicines and equipment during emergencies.
Results: From an initial yield of 4,294 articles, duplicates and irrelevant studies were removed, resulting in 34 articles eligible for full analysis. The review identified twelve predominant types of corruption that were particularly significant during the pandemic.
Conclusion: This scoping review highlights twelve broad categories of corruption that emerged as critical issues during the COVID-19 pandemic. Key forms of corruption included hoarding, falsification, theft, creation of fictitious bidders, procurement above the market price, document forgery, invoice falsification, failure to deliver goods, bribery, misappropriation, money laundering, abuse of power or position, nepotism, and favoritism. These findings provide valuable insights for healthcare managers and policymakers, facilitating the development of targeted strategies to prevent corruption and promote administrative integrity within medical supply chains, particularly in crisis contexts.
Keywords
- Haghdoost AA, Dehnavieh R, Kalavani K. The impact of COVID-19 on global health and the strategies to control it: the futures wheel model. Payesh 2021;20(5):629-31. doi:10.52547/ payesh.20.5.629
- Gereffi G. What does the COVID-19 pandemic teach us about global value chains? The case of medical supplies. J Int Bus Policy 2020;3(3):287-301. doi:10.1057/s42214-020-00062-w
- Iyengar KP, Vaishya R, Bahl S, Vaish A. Impact of the coronavirus pandemic on the supply chain in healthcare. Br J Healthcare Manag 2020;26(6):1-4. doi:10.12968/bjhc.2020.0047
- Knight L, Harland C, Telgen J, Thai KV, Callender G, McKen K. Public Procurement. Routledge; 2012.
- Abdou A, Czibik Á, Tóth B, Fazekas M. COVID-19 Emergency Public Procurement in Romania: Corruption Risks and Market Behavior. Government Transparency Institute; 2021. p. 1-6. doi:10.13140/rg.2.2.12108.54401
- Abdou A, Basdevant O, David-Barrett E, Fazekas M. Assessing Vulnerabilities to Corruption in Public Procurement and Their Price Impact. 2022. Available from: https://ssrn.com/ abstract = 4147325.
- Dikmen S, Çiçek HG. Fighting against corruption and bribery in public procurements during the COVID-19 pandemic. In: McGee RW, Benk S, eds. The Ethics of Bribery: Theoretical and Empirical Studies. Cham: Springer International Publishing; 2023. p. 309-28. doi:10.1007/978-3-031-17707-1_18
- Seidman G, Atun R. Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries. BMJ Glob Health 2017;2(2): e000243. doi:10.1136/bmjgh-2016-000243
- Teremetskyi V, Duliba Y, Kroitor V, Korchak N, Makarenko O. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of COVID-19. Med Leg J 2021;89(1):25-8. doi:10.1177/0025817220971925
- Rose-Ackerman S. Corruption and COVID-19. Eunomia Rev Cult Leg 2021(20):16-36.
- Kohler JC. Fighting Corruption in the Health Sector: Methods, Tools and Good Practices. United New York: Nations Development Programme (UNDP); 2011.
- Buseh AG, Stevens PE, Bromberg M, Kelber ST. The Ebola epidemic in West Africa: challenges, opportunities, and policy priority areas. Nurs Outlook 2015;63(1):30-40. doi:10.1016/j. outlook.2014.12.013
- Piatek OI, Ning JC, Touchette DR. National drug shortages worsen during COVID-19 crisis: proposal for a comprehensive model to monitor and address critical drug shortages. Am J Health Syst Pharm 2020;77(21):1778-85. doi:10.1093/ajhp/ zxaa228
- Pulk RA, Leber M, Tran L, Ammar M, Amin N, Miller L, et al. Dynamic pharmacy leadership during the COVID-19 crisis: optimizing patient care through formulary and drug shortage management. Am J Health Syst Pharm 2020;77(22):1874-84. doi:10.1093/ajhp/zxaa219
- Forman L, Kohler JC. Global health and human rights in the time of COVID-19: response, restrictions, and legitimacy. In: Rights at Stake and the COVID-19 Pandemic. Routledge; 2023. p. 33-42.
- Luz AO. Emergencies: Increasing the Opportunities to Corruption? Geneva Global Policy Briefs No. 1 of 2021. University of Geneva; 2021. Available from: https://ceje.ch/ files/4116/1521/7604/University_of_Geneva_-_GGPB_N1- 2021_-_A._Oliveira_Silva_Luz.pdf.
- Emrouzi R, Sahebkar Feiz Abadi F, Eshraghi A, Ghassemi M, Kalavani K, Akhondzardaini R. Corruption in healthcare procurement during the COVID-19 pandemic: identifying determinants and proposing comprehensive anti-corruption strategies. Asia Pac J Health Manag 2025;20(2): i4197. doi:10.24083/apjhm.v20i2.4197
- Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol 2005;8(1):19-32. doi:10.1080/1364557032000119616
- Agwu P, Orjiakor CT, Odii A, Onwujekwe O. Effects of corruption and unaccountability on responses of frontline health workers to COVID-19 in Nigeria: Lessons and considerations for the social work profession. Int Soc Work 2023;66(1):206-18. doi:10.1177/00208728211073391
- Kohler JC, Wright T. The urgent need for transparent and accountable procurement of medicine and medical supplies in times of COVID-19 pandemic. J Pharm Policy Pract 2020;13:58. doi:10.1186/s40545-020-00256-w
- Ademuyiwa AO. World Health Organization medical product alert N°6/2022: a clarion call for eternal vigilance. J Clin Sci 2022;19(4):111. doi:10.4103/jcls.jcls_71_22
- Ahmad RW, Salah K, Jayaraman R, Yaqoob I, Ellahham S, Omar M. Blockchain and COVID-19 pandemic: applications and challenges. Cluster Comput 2023:1-26. doi:10.1007/s10586- 023-04009-7
- Akokuwebe ME, Idemudia ES. Fraud within the Nigerian health system, a double threat for resilience of a health system and the response to the COVID-19 pandemic: a review. Pan Afr Med J 2023;45:116. doi:10.11604/pamj.2023.45.116.36979
- Arkorful VE, Lugu BK, Charway SM, Arkorful VA. SARSCOV-19 amidst corruption: does the civil society matter? - An empirical study. J Public Aff 2022: e2825. doi:10.1002/pa.2825
- Silverio-Murillo A, Prudencio D, Balmori-de-la-Miyar JR. The effect of the COVID-19 pandemic on risk of corruption. Public Organ Rev 2024;24(4):1293-313. doi:10.1007/s11115-024- 00765-1
- Elhassan Gadour MM. Corruption in public procurement: can e-procurement and artificial intelligence make a difference in Africa? QScience Connect 2024;2024(1):2. doi:10.5339/ connect.2024.spt.2
- Gonzalez-Aquines A, Kowalska-Bobko I. Addressing health corruption during a public health crisis through anticipatory governance: Lessons from the COVID-19 pandemic. Front Public Health 2022;10:952979. doi:10.3389/fpubh.2022.952979
- Balaeva O, Rodionova Y, Yakovlev A, Tkachenko A. Public procurement efficiency as perceived by market participants: the case of Russia. Int J Public Adm 2022;45(16):1156-67. do i:10.1080/01900692.2021.1964083
- Dralega CA, Napakol A. COVID-19 and the Media in Sub-Saharan Africa: Media Viability, Framing and Health Communication. Emerald Publishing Limited; 2022.
- Lustig N, Pabon VM, Sanz F, Younger SD. The impact of COVID-19 lockdowns and expanded social assistance on inequality, poverty and mobility in Argentina, Brazil, Colombia and Mexico. Covid Economics, Vetted and Real-Time Papers 2020;46:32-67.
- Sánchez-Ley L, Olmos R. Hijo de Bartlett Vendió al Gobierno el Ventilador COVID-19 Más Caro. Mexicanos Contra la Corrupción y la Impunidad; 2020. Available from: https:// contralacorrupcionmx/hijo-bartlett-ventilador-covid-19/. Accessed October 6, 2022.
- Hossain MM, Rahaman MM, Rahman MJ. COVID-19 corruption in the public health sector-emerging evidence from Bangladesh. Health Policy Plan 2023;38(7):799-821. doi:10.1093/heapol/ czad036
- Fazekas M, Hernández Sánchez A, Abdou A, Kofrán D. Corruption Risks in Public Procurement Through the COVID-19 Pandemic in Europe. Budapest: Government Transparency Institute; 2023. p. 50.
- Cuadrado DC. Corruption During COVID-19. Trends, Drivers, and Lessons Learned for Reducing Corruption in Health Emergencies. Bergen: Chr. Michelsen Institute; 2022.
- Faiola A, Herrero AV. A Pandemic of Corruption: $40 Masks, Questionable Contracts, Rice-Stealing Bureaucrats Mar Coronavirus Response. The Washington Post; 2020.
- Fishman A. “Worst of Brazil”: COVID-19 Vaccine Corruption Implicates Top Bolsonaro Allies. The Intercept; 2021. Available from: https://theintercept.com/2021/07/31/bolsonaro-brazil-covid-vaccine-corruption/.
- Ehrlich RS. COVID Corruption Rears its Ugliest Head in Vietnam. Asia Times; 2022. Available from: https://asiatimes. com/2022/07/covid-corruption-rears-its-ugliest-head-in-vietnam/.
- Cardona GK, Mendieta D. [Corruption the biggest epidemic that Colombia suffers]. Rev Opinião Juríd 2021;19(32):296-315.
- Rotkin KA. Good Practices Compendium on Combating Corruption in the Response to COVID-19. United Nations Office on Drugs and Crime; 2020. Available from: https:// wwwunodcorg/pdf/corruption/G20_Compendium_COVID-19_ FINALpdf.
- Mulyaman D, Ismail A, Rahmani AA, Damayanti A. The case of corruption in COVID-19 pandemic in Asia Pacific: study case of Indonesia. J Soc Stud 2023;19(1):41-54. doi:10.21831/ jss.v19i1.52377
- Farrelly B. Data in the Dark: A Look at COVID Corruption. Independent Australia; 2022. Available from: https://unishka. com/data-in-the-dark-a-look-at-covid-corruption/.
- Reporters F. MACC Probes 25 Cases Linked to COVID-19 Management. Free Malaysia Today; 2022. Available from: https://www.freemalaysiatoday.com/category/ nation/2022/06/02/macc-probes-25-cases-linked-to-covid- 19-management.
- Authority TCaA-C. The Control and Anti-Corruption Authority initiates a number of criminal cases. Accessed July 20, 2020. Available from: https://www.nazaha.gov.sa/News/ Details?q=ttxHvXxfBMMrpIjK/vAadw==
- Gorodensky A, Kohler JC. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines. J Pharm Policy Pract 2022;15(1):50. doi:10.1186/s40545-022-00442-y
- El Auditor.info. Para Poder Ciudadano no están garantizados los estándares mínimos de transparencia. 2021. Available from: https://elauditor.info/actualidad/para-poder-ciudadano-no-estan-garantizados-los-estandares-minimos-de-transparencia_ a5ff5c97d602a3403c6e52b81.
- European Council. Impact of Russia’s Invasion of Ukraine on the Markets: EU Response. European Council; 2022. Available from: https://www.consilium.europa.eu/en/policies/ eu-response-russia-military-aggression-against-ukraine-archive/ impact-of-russia-s-invasion-of-ukraine-on-the-markets-eu-response/.
- Europol. Europol Warning on the Illicit Sale of False Negative COVID-19 Test Certificates. Europol; 2021. Available from: https://www.europol.europa.eu/media-press/newsroom/news/ europol-warning-illicit-sale-of-false-negative-covid-19-test-certificates.
- Kalavani K, Mohebbifar R, Rafiei S. Evidence based practice among healthcare providers: a cross-sectional study. Int J Health Care Qual Assur 2019;32(5):867-78. doi:10.1108/ ijhcqa-08-2017-0162
- Ebadifard Azar F, Rezapour A, Mousavi Isfahani H, Azami- Aghdash S, Kalavani K, Mahmoudi F. Evidence- based medicine performance among health care providers in Iranian hospitals: a nationwide survey. Med J Islam Repub Iran 2017;31:77. doi:10.14196/mjiri.31.77
)